Pfizer to Begin Clinical Trial of COVID-19 Vaccine in Pregnant Women
FRIDAY, Feb. 19, 2021 -- The first U.S. participants in a large-scale clinical trial to test the safety and efficacy of the Pfizer COVID-19 vaccine in pregnant women have received their shots, the company announced Thursday.
The goal is to enroll about 4,000 pregnant women in the worldwide trial, which the company believes will be completed by January 2023, CBS News reported.
Without vaccination, research suggests pregnant women face a higher risk for hospitalization and death from COVID-19. One study published in January revealed a COVID-19 mortality rate among pregnant women that was 13 times higher than that of other similarly aged patients, CBS News reported.
"I recommend highly that all pregnant women be immunized, from initial discovery of the pregnancy right up to term," Bob Lahita, M.D., a professor of medicine at New York Medical College and chairman of medicine at St. Joseph University Hospital, told CBS News recently. He said there is "no evidence" that the vaccine "has any effect on the placenta, on the fetus, on the mother. Except if one gets the infection, the COVID, and you are pregnant, you run the risk of becoming very, very sick."
Pfizer also said it plans to start trials of the vaccine in younger children in the coming months and recently began trials in teens. Research to assess the vaccine in people with weakened immune systems is also planned, CBS News reported.
© 2021 HealthDay. All rights reserved.
Posted: February 2021
Further Support and Information on COVID-19
Read this next
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of Feb. 22 to 26, 2021. This roundup...
FRIDAY, Feb. 26, 2021 -- A centralized online portal to help Americans find nearby COVID-19 vaccination sites is being backed by the U.S. Centers for Disease Control and...
FRIDAY, Feb. 26, 2021 -- In a research letter published online Feb. 16 in Open Forum Infectious Diseases, cutaneous findings are described for multisystem inflammatory syndrome in...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.